AstraZeneca CEO Pascal Soriot unpacks President Donald Trump’s drug value reduce govt order on ‘The Claman Countdown.’
President Trump put pharmaceutical CEOs on discover, demanding they decrease drug costs or he promised to get entangled.
He penned a letter to 17 CEOs, in July, outlining what he needs from the pharma business to chop bills for shoppers.
In lots of circumstances, Individuals are paying larger costs for medicine that deal with frequent circumstances, whereas prospects in international nations pay much less.
FOX Enterprise takes a take a look at the highest 5 costliest medicine by gross sales within the U.S. and what they’re more likely to value shoppers out of pocket. This rundown doesn’t embrace coupons or particular waivers some prospects could also be eligible for.
Merck’s Keytruda – Numerous cancers
KEYTRUDA is a prescription medication used to deal with a number of cancers known as. (Merck )
$11,795 per dose each 3 weeks
Gross sales: $29.5 billion in international gross sales in 2024
Supply: Merck
Ticker Safety Final Change Change % MRK MERCK & CO. INC. 84.42 +0.51
+0.61%
Novo Nordisk’s Ozempic – Sort 2 Diabetes 
A customs investigator holds a bundle of Ozempic (weight reduction syringe). (Marcus Brandt/image alliance by way of Getty Photographs / Getty Photographs)
$997.58 per weekly pen for a 28-day provide. Nonetheless, the corporate tells FOX Enterprise “Most people don’t pay that price. In fact, nearly 90% of patients with insurance coverage for Ozempic® pay $25 or less.”
Whereas accredited for diabetes, it is generally used for weight reduction however isn’t FDA accredited for weight administration.
Gross sales: Over $17 billion in 2024
Supply: Novo Nordisk
Ticker Safety Final Change Change % NVO NOVO NORDISK A/S 48.47 +0.22
+0.45%
Eli Lilly’s Mounjaro – Diabetes, weight reduction 
Mounjaro injectible pen is a drug has turn out to be in style for aiding with weight reduction. (Sandy Huffaker for The Washington Submit by way of Getty Photographs / Getty Photographs)
Round $1,080 monthly for a 28‑day provide of 4 pens
Gross sales: $11.5 billion in international gross sales 2024
Ticker Safety Final Change Change % LLY ELI LILLY & CO. 926.27 +18.72
+2.06%
Bristol-Myers Squibb/Pfizer’s Eliquis – blood thinner 
On this photograph illustration, Eliquis. It’s certainly one of 10 pharmaceuticals that will likely be topic to Medicare value negotiations beneath the Inflation Discount Act. The opposite medicine embrace Farxiga, Xarelto, Entresto, Jardiance, Enbrel, Januvia, Imbruvica, (Illustration by Scott Olson/Getty Photographs) / Getty Photographs)
$500-$600 monthly
Gross sales: $11.4 billion in 2024 gross sales
Ticker Safety Final Change Change % BMY BRISTOL MYERS SQUIBB CO. 46.47 +0.84
+1.85%
Gilead Science’s Biktarvy – HIV 
Scott McCauley, an affiliate scientist at Gilead Sciences Inc., makes human proteins on the Gilead laboratory in Foster Metropolis, California. The corporate is the world’s largest maker of AIDS medicine. (Photographer: David Paul Morris/Bloomberg by way of Getty Photographs / Getty Photographs)
$2,000-$3,000 monthly
Gross sales: $10 billion in 2024
Supply: Corporations
